These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2522314)

  • 1. Antithrombotic and bleeding effects of glycosaminoglycans with different degrees of sulphation.
    Van Ryn-McKenna J; Ofosu FA; Hirsh J; Buchanan MR
    Br J Haematol; 1989 Feb; 71(2):265-9. PubMed ID: 2522314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The haemorrhagic and antithrombotic effects of dermatan sulphate.
    Fernandez F; Van Ryn J; Ofosu FA; Hirsh J; Buchanan MR
    Br J Haematol; 1986 Oct; 64(2):309-17. PubMed ID: 3778825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
    Ofosu FA; Modi GJ; Blajchman MA; Buchanan MR; Johnson EA
    Biochem J; 1987 Dec; 248(3):889-96. PubMed ID: 2963622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo.
    Boneu B; Buchanan MR; Cade JF; Van Ryn J; Fernandez FF; Ofosu FA; Hirsh J
    Thromb Res; 1985 Oct; 40(1):81-9. PubMed ID: 4089829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
    Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB
    Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate, and heparin.
    Hoppensteadt D; Racanelli A; Walenga JM; Fareed J
    Semin Thromb Hemost; 1989 Oct; 15(4):378-85. PubMed ID: 2530633
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of glycosaminoglycans by human skin fibroblasts cultured on collagen gels.
    Gallagher JT; Gasiunas N; Schor SL
    Biochem J; 1980 Aug; 190(2):243-54. PubMed ID: 7470051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model.
    Maggi A; Abbadini M; Pagella PG; Borowska A; Pangrazzi J; Donati MB
    Haemostasis; 1987; 17(6):329-35. PubMed ID: 3428718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study on glycosaminoglycans synthesized in peripheral and peritoneal polymorphonuclear leucocytes from guinea pigs.
    Ohhashi Y; Hasumi F; Mori Y
    Biochem J; 1984 Jan; 217(1):199-207. PubMed ID: 6696721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The venous antithrombotic profile of naroparcil in the rabbit.
    Millet J; Theveniaux J; Brown NL
    Thromb Haemost; 1994 Dec; 72(6):874-9. PubMed ID: 7740457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and anticoagulant activity of fully O-sulphonated glycosaminoglycans.
    Toida T; Maruyama T; Ogita Y; Suzuki A; Toyoda H; Imanari T; Linhardt RJ
    Int J Biol Macromol; 1999 Dec; 26(4):233-41. PubMed ID: 10569284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
    Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS
    Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of glycosaminoglycans on coagulation: a thromboelastographic study.
    Senzolo M; Coppell J; Cholongitas E; Riddell A; Triantos CK; Perry D; Burroughs AK
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):227-36. PubMed ID: 17413758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of heparin, dermatan sulfate and of their association on the inhibition of venous thrombosis growth in the rabbit.
    Carrie D; Caranobe C; Gabaig AM; Larroche M; Boneu B
    Thromb Haemost; 1992 Dec; 68(6):637-41. PubMed ID: 1287877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is heparin the ideal anticoagulant for cardiopulmonary bypass? Dermatan sulphate may be an alternate choice.
    Brister SJ; Ofosu FA; Heigenhauser GJ; Gianese F; Buchanan MR
    Thromb Haemost; 1994 Apr; 71(4):468-73. PubMed ID: 8052965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synopsis of the anticoagulant and antithrombotic profile of the low molecular weight heparinoid Org 10172 in experimental models.
    Meuleman DG
    Semin Thromb Hemost; 1989 Oct; 15(4):370-2. PubMed ID: 2479103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II.
    Tovar AM; de Mattos DA; Stelling MP; Sarcinelli-Luz BS; Nazareth RA; Mourão PA
    Biochim Biophys Acta; 2005 Apr; 1740(1):45-53. PubMed ID: 15878740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta induces selective increase of proteoglycan production and changes in the copolymeric structure of dermatan sulphate in human skin fibroblasts.
    Westergren-Thorsson G; Schmidtchen A; Särnstrand B; Fransson LA; Malmström A
    Eur J Biochem; 1992 Apr; 205(1):277-86. PubMed ID: 1555588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dermatan sulfate and the prevention of experimental venous thrombosis].
    Desnoyers P; Bara L; Samama M
    Pathol Biol (Paris); 1989 Jun; 37(6):759-67. PubMed ID: 2674877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosaminoglycans in early chick embryo.
    Skandalis SS; Theocharis AD; Papageorgakopoulou N; Zagris N
    Int J Dev Biol; 2003 May; 47(4):311-4. PubMed ID: 12755338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.